SUBA-Itraconazole: Phase II started

HGN began an open-label Phase II in 12 patients. HGN has exclusive rights to SUBA-itraconazole outside of Australia and New Zealand from Mayne Pharma Pty Ltd., which was acquired by HSP earlier this y...